Treatment of biliary tract cancer with NVP-AEW541: Mechanisms of action and resistance

doi:10.3748/wjg.v16.i2.156

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 16, Issue 2

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (4430)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-5) series, Tables (1-1) series.

Item

Count

PDF

427

HTML

3634

Figures (1-5)

227

Tables (1-1)

142

Sum=4430

Jan 14, 2010 (publication date) through Jul 16, 2024

Times Cited of This Article

Times Cited (23)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Original Article

World J Gastroenterol. Jan 14, 2010; 16(2): 156-166
Published online Jan 14, 2010. doi: 10.3748/wjg.v16.i2.156

Full Size Figure Download Figure

Figure 4 Influence of NVP-AEW541 (3 d treatment with calculated IC₅₀) on mRNA expression of IGF-1R ligands IGF-1 and IGF-2 in two of the tested cell lines. Ratio of IGF mRNA expression in treated vs untreated cell lines is shown (n = 3).

Citation: Wolf S, Lorenz J, Mössner J, Wiedmann M. Treatment of biliary tract cancer with NVP-AEW541: Mechanisms of action and resistance. World J Gastroenterol 2010; 16(2): 156-166
URL: https://www.wjgnet.com/1007-9327/full/v16/i2/156.htm
DOI: https://dx.doi.org/10.3748/wjg.v16.i2.156